Ginsenoside-Rh1-Prosapogenin-A2-DataSheet-MedChemExpress_第1頁
Ginsenoside-Rh1-Prosapogenin-A2-DataSheet-MedChemExpress_第2頁
Ginsenoside-Rh1-Prosapogenin-A2-DataSheet-MedChemExpress_第3頁
Ginsenoside-Rh1-Prosapogenin-A2-DataSheet-MedChemExpress_第4頁
全文預覽已結束

下載本文檔

版權說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權,請進行舉報或認領

文檔簡介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEGinsenoside Rh1Cat. No.: HY-N0604CAS No.: 63223-86-9Synonyms: Prosapogenin A2; Sanchinoside B2; Sanchinoside Rh1分式: CHO分量: 638.87作靶點: PPAR; TNF Receptor; Interleukin Related作通路: Cell Cycle/DNA Damage; Apoptosis;Immunology/Inflam

2、mation儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實驗 DMSO : 100 mg/mL (156.53 mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 1.5653 mL 7.8263 mL 15.6526 mL5 mM 0.3131 mL 1.5653 mL 3.1305 mL10 mM 0.1565 mL 0.7826 mL 1.5653 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合

3、適的溶劑配制儲備液,并請注意儲備液的保存式和期限。體內(nèi)實驗請根據(jù)您的實驗動物和給藥式選擇適當?shù)娜芙獍福渲魄罢埾扰渲瞥吻宓膬湟?,再依次添加助溶?為保證實驗結果的可靠性,體內(nèi)實驗的作液,建議您現(xiàn)現(xiàn)配,當天使;澄清的儲備液可以根據(jù)儲存條件,適當保存;以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占):1. 請依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (3.91 mM); Clear solution2. 請依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in sal

4、ine)Solubility: 2.5 mg/mL (3.91 mM); Clear solution1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemE3. 請依序添加每種溶劑: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (3.91 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 Ginsenoside Rh1 (Prosapogenin A2; Sanchinoside B2; Sanchinoside Rh1)是從 Panax Ginseng 根部分離的。Gins

5、enoside Rh1 抑制 PPAR-,TNF-,IL-6 和 IL-1 的表達。IC50 & Target PPAR- IL-6 IL-1 TNF-體外研究 The effect of Ginsenoside Rh1 is examined on adipogenesis in 3T3-L1 cells. Ginsenoside Rh1 potentlyinhibits the adipogenesis, as assessed by Oil-red O staining and lipid contents in 3T3-L1 adipocytes.Ginsenoside Rh1, at

6、 concentrations of 50 M and 100 M, inhibit the adipogenesis by 50% and 63%,respectively.The expression levels of adipocytespecific genes such as PPAR-, C/EBP-, FAS, aFABP andsome genes are examined during early phase of differentiation such as Pref-1, C/EBP- and Glucocorticoidreceptor (GR). After th

7、e treatment with Ginsenoside Rh1 in 3T3-L1 cells, mRNA is extracted on 18 h and 24h for Pref-1, C/EBP- and GR and day 8 for PPAR-, C/EBP-, FAS, aFABP. Then, the expression profiles ofadipocyte-specific genes are investigated by RT-PCR. PPAR-, C/EBP-, FAS, and aFABP expressions aresignificantly incre

8、ased in DMI-stimulated differentiated adipocyte compared to those of non-stimulatedadipocyte cells. However, treatment with DMI in the presence of Ginsenoside Rh1 significantly suppressesthe expression levels of PPAR-, C/EBP-, FAS, and aFABP in a dose- dependent manner, whereas theexpression levels

9、of Pref-1, C/EBP- and GR are not affected 1.體內(nèi)研究 When high-fat diet (HFD) fed mice for 8 weeks, body and epididymal fat weight gains are significantlyincreased compared to those of low-fat diet (LFD)-fed mice. However, when Ginsenoside Rh1 is treated inHFD-fed mice, body and epididymal fat weight ga

10、ins are significantly decrease compared with those of theHFD-fed mice. TG, glucose, insulin, total cholesterol, and HDL levels in the blood are significantly increasedin HFD-fed mice group compared to LFD-fed mice group. Treatment with Ginsenoside Rh1 in HFD-fed micesignificantly lowers TG level alo

11、ne 1.PROTOCOLCell Assay 1 Mouse embryo fibroblasts 3T3-L1 cells are incubated in DMEM, containing 10% FBS and 1% AB, at 37Cand 5.6% CO2 atmosphere. To induce differentiation, two days after confluence, preadipocytes (designatedday 0) are cultured in the differentiation medium (DM), which is consiste

12、d of DMEM, 10% FBS, 1% AB, andDMI (0.28 unit/mL insulin, 0.5 mM Isobutylmethylxanthine and 1 M Dexamethasone) for 2 d in the presenceor absence of 50 M and 100 M of Ginsenoside Rh1, and switched to DM containing 10% FBS and 10 g/mL insulin and then changed to DMEM medium with 10% FBS for every 2 d 1

13、.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Mice 1Administration 1 Male C57BL/6J mice are separated into 3 groups, LFD, HFD and HFDRh1. Each group is consisted of ten2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEmice. LFD group fed LFD fo

14、r 8 weeks. HFD group fed HFD for 8 weeks. HFDRh1 group fed HFD diet for 4weeks and then simultaneously treated with HFD and 20 mg/kg/d Ginsenoside Rh1, which is orallyadministrated. Weight and food intake of mice are measured daily. After finishing treatment for 4 weeks,blood and epididymal fats are collected for further analysis.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Gu W, et al. Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation. Biol Pharm

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
  • 4. 未經(jīng)權益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
  • 6. 下載文件中如有侵權或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論